By Debdeep Gupta | 22 May, 2026
Sun Pharma Q4 Results: Net profit jumps 26% to Rs 2,714 crore; board proposes Rs 5 final dividend
Sun Pharmaceutical Industries reported a 26.2 percent year-on-year rise in consolidated net profit for the fourth quarter of FY26 at Rs 2,714 crore, supported by strong growth in its India business and innovative medicines portfolio. The company's board has proposed a final dividend of Rs 5 per equity share for FY26.Consolidated revenue from operations increased 13.6 percent on-year to Rs 14,559.8...





Live Comments